Fremanezumab for episodic migraine prevention demonstrates positive phase 3 data
Both monthly migraine days and headache days were reduced vs placebo in patients aged 6 to 17 years.
Food Insecurity and the Dangers of Infant Formula Dilution
Upadacitinib effective in treating atopic dermatitis through 76 weeks
In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).
Demystifying Infant Formula
Saol Therapeutics submits NDA for SL1009 to treat Pyruvate Dehydrogenase Complex Deficiency
If approved, SL1009 has the potential to be the first approved medication for PDCD, and would be available as an oral solution.
Forget protein—This is the nutrient kids need
Colleen Sloan, PA-C, RDN, unpacks the essential nutrient children are missing in their diets and how providers and parents can start implementing.
